Natural killer cell regulation by MicroRNAs in health and disease

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Leong, Jeffrey W ^a   Sullivan, Ryan P ^a   Fehniger, Todd A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

AGGRESSIVE NK CELL LEUKEMIA; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; GENE EXPRESSION; HUMAN; NATURAL KILLER CELL; NONHUMAN; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; ANIMAL; BIOLOGICAL MODEL; DISEASES; GENE EXPRESSION REGULATION; GENETICS; HEALTH; METABOLISM; PATHOLOGY;

ANIMALS; DISEASE; GENE EXPRESSION REGULATION; HEALTH; HUMANS; KILLER CELLS, NATURAL; MICRORNAS; MODELS, BIOLOGICAL;

EID: 84871361135     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/632329     Document Type: Review

References (103)

1. Yokoyama W. M., Kim S., French A. R., The dynamic life of natural killer cells. Annual Review of Immunology 2004 22 11 405 429 10.1146/annurev.immunol. 22.012703.104711 (Pubitemid 38680428)
2. Lanier L. L., Up on the tightrope: natural killer cell activation and inhibition. Nature Immunology 2008 9 5 495 502 2-s2.0-42449102990 10.1038/ni1581 (Pubitemid 351560518)
3. di Santo J. P., Natural killer cells: diversity in search of a niche. Nature Immunology 2008 9 5 473 475 10.1038/ni.f.201 (Pubitemid 351560514)
4. Caligiuri M. A., Human natural killer cells. Blood 2008 112 3 461 469 2-s2.0-50949124847 10.1182/blood-2007-09-077438
5. Freud A. G., Caligiuri M. A., Human natural killer cell development. Immunological Reviews 2006 214 1 56 72 2-s2.0-33750686595 10.1111/j.1600-065X. 2006.00451.x (Pubitemid 44707902)
6. Colucci F., Caligiuri M. A., di Santo J. P., What does it take to make a natural killer? Nature Reviews Immunology 2003 3 5 413 425 2-s2.0-0037711333 10.1038/nri1088 (Pubitemid 37323201)
7. Chiossone L., Chaix J., Fuseri N., Roth C., Vivier E., Walzer T., Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009 113 22 5488 5496 2-s2.0-67049114093 10.1182/blood-2008-10-187179
8. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S., Functions of natural killer cells. Nature Immunology 2008 9 5 503 510 2-s2.0-42449151214 10.1038/ni1582 (Pubitemid 351560519)
9. Jonsson A. H., Yokoyama W. M., Chapter 2 natural killer cell tolerance. Licensing and other mechanisms. Advances in Immunology 2009 101 27 79 2-s2.0-60449110935 10.1016/S0065-2776(08)01002-X
10. Joncker N. T., Raulet D. H., Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunological Reviews 2008 224 1 85 97 2-s2.0-49249089100 10.1111/j.1600-065X. 2008.00658.x
11. Lanier L. L., NK cell recognition. Annual Review of Immunology 2005 23 225 274 10.1146/annurev.immunol.23.021704.115526 (Pubitemid 40563170)
12. Bryceson Y. T., Long E. O., Line of attack: NK cell specificity and integration of signals. Current Opinion in Immunology 2008 20 3 344 352 10.1016/j.coi.2008.03.005
13. Lee S. H., Miyagi T., Biron C. A., Keeping NK cells in highly regulated antiviral warfare. Trends in Immunology 2007 28 6 252 259 2-s2.0-34249310719 10.1016/j.it.2007.04.001 (Pubitemid 46810349)
14. Fehniger T. A., Cai S. F., Cao X., Bredemeyer A. J., Presti R. M., French A., Ley T. J., Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of Granzyme B and perforin mRNAs. Immunity 2007 26 6 798 811 2-s2.0-34250200713 10.1016/j.immuni.2007.04.010 (Pubitemid 46907665)
15. Lucas M., Schachterle W., Oberle K., Aichele P., Diefenbach A., Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007 26 4 503 517 2-s2.0-34247100277 10.1016/j.immuni.2007.03.006 (Pubitemid 46602996)
16. Chaix J., Tessmer M. S., Hoebe K., Fuséri N., Ryffel B., Dalod M., Alexopoulou L., Beutler B., Brossay L., Vivier E., Walzer T., Cutting edge: priming of NK cells by IL-18. Journal of Immunology 2008 181 3 1627 1631 2-s2.0-49649105001
17. Orange J. S., Human natural killer cell deficiencies. Current Opinion in Allergy and Clinical Immunology 2006 6 6 399 409 2-s2.0-33750800121 10.1097/ACI.0b013e3280106b65 (Pubitemid 44714151)
18. Orange J. S., Ballas Z. K., Natural killer cells in human health and disease. Clinical Immunology 2006 118 1 1 10 2-s2.0-29444459408 10.1016/j.clim.2005.10.011 (Pubitemid 43012040)
19. Kuijpers T. W., Baars P. A., Dantin C., van den Burg M., Van Lier R. A. W., Roosnek E., Human NK cells can control CMV infection in the absence of T cells. Blood 2008 112 3 914 915 2-s2.0-50949100398 10.1182/blood-2008-05-157354
20. Biron C. A., Brossay L., NK cells and NKT cells in innate defense against viral infections. Current Opinion in Immunology 2001 13 4 458 464 2-s2.0-0035424543 10.1016/S0952-7915(00)00241-7 (Pubitemid 32728479)
21. Vidal S. M., Khakoo S. I., Biron C. A., Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Current Opinion in Immunology 2011 1 6 497 512
22. Farag S. S., Fehniger T. A., Ruggeri L., Velardi A., Caligiuri M. A., Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002 100 6 1935 1947 2-s2.0-0037105453 10.1182/blood-2002-02-0350 (Pubitemid 35001221)
23. Ljunggren H. G., Malmberg K. J., Prospects for the use of NK cells in immunotherapy of human cancer. Nature Reviews Immunology 2007 7 5 329 339 10.1038/nri2073 (Pubitemid 46674487)
24. Wu J., Lanier L. L., Natural killer cells and cancer. Advances in Cancer Research 2010 13 7 731 736
25. Velardi A., Ruggeri L., Mancusi A., Aversa F., Christiansen F. T., Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia. Current Opinion in Immunology 2009 21 5 525 530 2-s2.0-70349817631 10.1016/j.coi.2009.07.015
26. Hsu K. C., Dupont B., Natural killer cell receptors: regulating innate immune responses to hematologic malignancy. Seminars in Hematology 2005 42 2 91 103 2-s2.0-17444428649 10.1053/j.seminhematol.2005.01.010 (Pubitemid 40544299)
27. Imai K., Matsuyama S., Miyake S., Suga K., Nakachi K., Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. The Lancet 2000 356 9244 1795 1799 2-s2.0-0034715948
28. Shuptrine C., Surana R., Weiner L. M., Monoclonal antibodies for the treatment of cancer. Seminars in Cancer Biology 2012 22 1 3 13
29. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W. D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M. F., Velardi A., Effectiveness of donor natural killer cell aloreactivity in mismatched hematopoietic transplants. Science 2002 295 5562 2097 2100 2-s2.0-0037086131 10.1126/science.1068440 (Pubitemid 34229476)
30. Miller J. S., Soignier Y., Panoskaltsis-Mortari A., McNearney S. A., Yun G. H., Fautsch S. K., McKenna D., Le C., Defor T. E., Burns L. J., Orchard P. J., Blazar B. R., Wagner J. E., Slungaard A., Weisdorf D. J., Okazaki I. J., McGlave P. B., Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005 105 8 3051 3057 2-s2.0-20144388509 10.1182/blood-2004-07-2974
31. Yamanaka Y., Tagawa H., Takahashi N., Watanabe A., Guo Y., Iwamoto K., Yamashita J., Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 2009 114 15 3265 3275
32. Hesslein D. G. T., Lanier L. L., Transcriptional control of natural killer cell development and function. Advances in Immunology 2011 109 45 85 2-s2.0-79955723001 10.1016/B978-0-12-387664-5.00002-9
33. Ramirez K., Kee B. L., Transcriptional regulation of natural killer cell development. Current Opinion in Immunology 2010 22 2 193 198 10.1016/j.coi.2010.02.002
34. Stetson D. B., Mohrs M., Reinhardt R. L., Baron J. L., Wang Z. E., Gapin L., Kronenberg M., Locksley R. M., Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. Journal of Experimental Medicine 2003 198 7 1069 1076 2-s2.0-0141924778 10.1084/jem.20030630 (Pubitemid 37248622)
35. Wang P., Gu Y., Zhang Q., Han Y., Hou J., Lin L., Wu C., Bao Y., Su X., Jiang M., Wang Q., Li N., Cao X., Identification of resting and type I IFN-activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity. The Journal of Immunology 189 1 211 221
36. Liu X., Wang Y., Sun Q., Yan J., Huang J., Zhu S., Yu J., Identification of microRNA transcriptome involved in human natural killer cell activation. Immunology Letters 2012 143 2 208 217 10.1016/j.imlet.2012.02.014
37. Fehniger T. A., Wylie T., Germino E., Leong J. W., Magrini V. J., Koul S., Keppel C. R., Schneider S. E., Koboldt D. C., Sullivan R. P., Heinz M. E., Crosby S. D., Nagarajan R., Ramsingh G., Link D. C., Ley T. J., Mardis E. R., Next-generation sequencing identifies the natural killer cell microRNA transcriptome. Genome Research 2010 20 11 1590 1604 2-s2.0-78649242699 10.1101/gr.107995.110
38. Bezman N. A., Cedars E., Steiner D. F., Blelloch R., Hesslein D. G. T., Lanier L. L., Distinct requirements of microRNAs in NK cell activation, survival, and function. Journal of Immunology 2010 185 7 3835 3846 2-s2.0-77958134781 10.4049/jimmunol.1000980
39. Sullivan R. P., Leong J. W., Schneider S. E., Keppel C. K. R., Germino E., French A. R., Fehniger T. A., MicroRNA deficient NK cells exhibit decreased survival but enhanced function. The Journal of Immunology 2012 188 7 3019 3030 10.4049/jimmunol.1102294
40. Thomas M. F., Abdul-Wajid S., Panduro M., Babiarz J. E., Rajaram M., Woodruff P., Lanier L. L., Heissmeyer V., Ansel K. M., Eri1 regulates microRNA homeostasis and mouse lymphocyte development and anti-viral function. Blood 2012 120 1 130 142 10.1182/blood-2011-11-394072
41. He L., Hannon G. J., MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics 2004 5 7 522 531 2-s2.0-3042767202 10.1038/nrg1379 (Pubitemid 38868508)
42. Vasudevan S., Tong Y., Steitz J. A., Switching from repression to activation: microRNAs can up-regulate translation. Science 2007 318 5858 1931 1934 2-s2.0-36749026906 10.1126/science.1149460
43. Kim V. N., MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology 2005 6 5 376 385 2-s2.0-18344369543 10.1038/nrm1644 (Pubitemid 40637855)
44. Wu L., Belasco J. G., Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Molecular Cell 2008 29 1 1 7 2-s2.0-38148999355 10.1016/j.molcel.2007.12.010
45. Filipowicz W., Bhattacharyya S. N., Sonenberg N., Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nature Reviews Genetics 2008 9 2 102 114 2-s2.0-38349169664 10.1038/nrg2290
46. Liu J., Control of protein synthesis and mRNA degradation by microRNAs. Current Opinion in Immunology 2008 20 2 214 221
47. Kasinski A. L., Slack F. J., MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nature Reviews Cancer 2011 11 12 849 864 10.1038/nrc3166
48. Lovat F., Valeri N., Croce C. M., MicroRNAs in the pathogenesis of cancer. Seminars in Oncology 2011 38 6 724 733 10.1053/j.seminoncol.2011.08.006
49. O'Connell R. M., Rao D. S., Chaudhuri A. A., Baltimore D., Physiological and pathological roles for microRNAs in the immune system. Nature Reviews Immunology 2010 10 2 111 122 2-s2.0-75649139134 10.1038/nri2708
50. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A. O., Landthaler M., Lin C., Socci N. D., Hermida L., Fulci V., Chiaretti S., Foà R., Schliwka J., Fuchs U., Novosel A., Müller R. U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D. B., Choksi R., De Vita G., Frezzetti D., Trompeter H. I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C. E., Nagle J. W., Ju J., Papavasiliou F. N., Benzing T., Lichter P., Tam W., Brownstein M. J., Bosio A., Borkhardt A., Russo J. J., Sander C., Zavolan M., Tuschl T., A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007 129 7 1401 1414 2-s2.0-34250877841 10.1016/j.cell.2007.04.040 (Pubitemid 46970709)
51. + T cells by the microRNA miR-125b. Nature Immunology 2011 12 796 803 2-s2.0-79959486788 10.1038/ni.2057
52. Allantaz F., Cheng D. T., Bergauer T., Ravindran P., Rossier M. F., Ebeling M., Badi L., Reis B., Bitter H., 'Asaro M. D., Chiappe A., Sridhar S., Pacheco G. D., Burczynski M. E., Hochstrasser D., Vonderscher J., Matthes T., Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One 2012 7 1 e29979
53. Muljo S. A., Ansel K. M., Kanellopoulou C., Livingston D. M., Rao A., Rajewsky K., Aberrant T cell differentiation in the absence of Dicer. Journal of Experimental Medicine 2005 202 2 261 269 2-s2.0-22944433872 10.1084/jem.20050678 (Pubitemid 41043822)
54. Chong M. M. W., Rasmussen J. P., Rudensky A. Y., Littman D. R., The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. Journal of Experimental Medicine 2008 205 10 2449 2-s2.0-53349171357 10.1084/jem.20071219090508c
55. de Boer J., Williams A., Skavdis G., Harker N., Coles M., Tolaini M., Norton T., Williams K., Roderick K., Potocnik A. J., Kioussis D., Transgenic mice with hematopoietic and lymphoid specific expression of Cre. European Journal of Immunology 2003 33 2 314 325 2-s2.0-0037332003 10.1002/immu.200310005 (Pubitemid 36267595)
56. Eckelhart E., Warsch W., Zebedin E., Simma O., Stoiber D., Kolbe T., Rülicke T., Mueller M., Casanova E., Sexl V., A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 2011 117 5 1565 1573 2-s2.0-79551643771 10.1182/blood-2010-06-291633
57. Narni-Mancinelli E., Chaix J., Fenis A., Kerdiles Y. M., Yessaad N., Reynders A., Gregoire C., Luche H., Ugolini S., Tomasello E., Walzer T., Vivier E., Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proceedings of the National Academy of Sciences of the United States of America 2011 108 45 18324 18329 2-s2.0-81055145276 10.1073/pnas.1112064108
58. di Santo J. P., Natural killer cell developmental pathways: a question of balance. Annual Review of Immunology 2006 24 257 286 10.1146/annurev.immunol. 24.021605.090700
59. Monticelli S., Ansel K. M., Xiao C., Socci N. D., Krichevsky A. M., Thai T. H., Rajewsky N., Marks D. S., Sander C., Rajewsky K., Rao A., Kosik K. S., MicroRNA profiling of the murine hematopoietic system. Genome biology 2005 6 8 R71 2-s2.0-24644489402
60. Zhou B., Wang S., Mayr C., Bartel D. P., Lodish H. F., miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proceedings of the National Academy of Sciences of the United States of America 2008 104 17 7080 7085 2-s2.0-56649100636 10.1073/pnas.0809324105 (Pubitemid 47186012)
61. Xiao C., Calado D. P., Galler G., Thai T. H., Patterson H. C., Wang J., Rajewsky N., Bender T. P., Rajewsky K., MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007 131 1 146 159 2-s2.0-34547941361 10.1016/j.cell.2007.07.021 (Pubitemid 47498525)
62. Ghisi M., Corradin A., Basso K., Frasson C., Serafin V., Mukherjee S., Mussolin L., Ruggero K., Bonanno L., Guffanti A., De Bellis G., Gerosa G., Stellin G., D'Agostino D. M., Basso G., Bronte V., Indraccolo S., Amadori A., Zanovello P., Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 2011 117 26 7053 7062 2-s2.0-79959842615 10.1182/blood-2010-12-326629
63. Bezman N. A., Chakraborty T., Bender T., Lanier L. L., miR-150 regulates the development of NK and iNKT cells. The Journal of Experimental Medicine. In press
64. Chen C. Z., Li L., Lodish H. F., Bartel D. P., MicroRNAs modulate hematopoietic lineage differentiation. Science 2004 303 5654 83 86 2-s2.0-0346727524 10.1126/science.1091903 (Pubitemid 38055775)
65. Li Q. J., Chau J., Ebert P. J. R., Sylvester G., Min H., Liu G., Braich R., Manoharan M., Soutschek J., Skare P., Klein L. O., Davis M. M., Chen C. Z., miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007 129 1 147 161 2-s2.0-33947721625 10.1016/j.cell.2007.03.008 (Pubitemid 46507589)
66. Cichocki F., Felices M., McCullar V., Presnell S. R., Al-Attar A., Lutz C. T., Miller J. S., Cutting Edge: microRNA-181 promotes human NK cell development by regulating notch signaling. The Journal of Immunology 2011 187 12 6171 6175 10.4049/jimmunol.1100835
67. Bachanova V., McCullar V., Lenvik T., Wangen R., Peterson K. A., Ankarlo D. E. M., Panoskaltsis-Mortari A., Wagner J. E., Miller J. S., Activated notch supports development of cytokine producing NK cells which are hyporesponsive and fail to acquire NK cell effector functions. Biology of Blood and Marrow Transplantation 2009 15 2 183 194 2-s2.0-58649111267 10.1016/j.bbmt.2008.11.031
68. Haraguchi K., Suzuki T., Koyama N., Kumano K., Nakahara F., Matsumoto A., Yokoyama Y., Sakata-Yanagimoto M., Masuda S., Takahashi T., Kamijo A., Takahashi K., Takanashi M., Okuyama Y., Yasutomo K., Sakano S., Yagita H., Kurokawa M., Ogawa S., Chiba S., Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15 1. Journal of Immunology 2009 182 10 6168 6178 2-s2.0-70350670384 10.4049/jimmunol.0803036
69. + cord blood hematopoietic progenitor cells. Biology of Blood and Marrow Transplantation 2009 15 9 1026 1037 2-s2.0-67849129018 10.1016/j.bbmt.2009.06.002
70. Young H. A., Regulation of interferon- γ gene expression. Journal of Interferon and Cytokine Research 1996 16 8 563 568 2-s2.0-0029819030
71. Khabar K. S. A., Young H. A., Post-transcriptional control of the interferon system. Biochimie 2007 89 6-7 761 769 2-s2.0-34347214770 10.1016/j.biochi.2007.02.008 (Pubitemid 47001636)
72. Huang Y., Lei Y., Zhang H., Hou L., Zhang M., Dayton A. I., MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of interleukin-12 signaling in human natural killer cells. Blood 2011 6793 6802
73. Jiang S., Li C., Olive V., Lykken E., Feng F., Sevilla J., Wan Y., He L., Li Q. J., Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 2011 118 20 5487 5497 10.1182/blood-2011-05-355644
74. Ma F., Xu S., Liu X., Zhang Q., Xu X., Liu M., Hua M., Li N., Yao H., Cao X., The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon- γ Nature Immunology 2011 12 861 869 2-s2.0-79960537747 10.1038/ni.2073
75. Steiner D. F., Thomas M. F., Hu J. K., Yang Z., Babiarz J. E., Allen C.D. C., Matloubian M., Blelloch R., Ansel K., MicroRNA-29 regulates T-box transcription factors and interferon- γ production in helper T cells. Immunity 2011 35 2 169 181 2-s2.0-79960892243 10.1016/j.immuni.2011.07.009
76. Rodriguez A., Vigorito E., Clare S., Warren M. V., Couttet P., Soond D. R., Van Dongen S., Grocock R. J., Das P. P., Miska E. A., Vetrie D., Okkenhaug K., Enright A. J., Dougan G., Turner M., Bradley A., Requirement of bic/microRNA-155 for normal immune function. Science 2007 316 5824 608 611 2-s2.0-34247584465 10.1126/science.1139253 (Pubitemid 46683148)
77. Thai T. H., Calado D. P., Casola S., Ansel K. M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J. L., Schmidt-Supprian M., Rajewsky N., Yancopoulos G., Rao A., Rajewsky K., Regulation of the germinal center response by MicroRNA-155. Science 2007 316 5824 604 608 2-s2.0-34247594818 10.1126/science.1141229 (Pubitemid 46683147)
78. Vigorito E., Perks K. L., Abreu-Goodger C., Bunting S., Xiang Z., Kohlhaas S., Das P. P., Miska E. A., Rodriguez A., Bradley A., Smith K. G. C., Rada C., Enright A. J., Toellner K. M., MacLennan I. C. M., Turner M., microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007 27 6 847 859 2-s2.0-37049002638 10.1016/j.immuni.2007.10. 009 (Pubitemid 350258623)
79. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., Papavasiliou F. N., MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008 28 5 621 629 2-s2.0-43049178852 10.1016/j.immuni.2008.03.015
80. O'Connell R. M., Kahn D., Gibson W. S. J., Round J. L., Scholz R. L., Chaudhuri A. A., Kahn M. E., Rao D. S., Baltimore D., MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010 33 4 607 619 2-s2.0-77958495102 10.1016/j.immuni.2010.09.009
81. Kohlhaas S., Garden O. A., Scudamore C., Turner M., Okkenhaug K., Vigorito E., Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells1. Journal of Immunology 2009 182 5 2578 2582 2-s2.0-64849100152 10.4049/jimmunol.0803162
82. Lu C., Huang X., Zhang X., Roensch K., Cao Q., Nakayama K. I., Blazar B. R., Zeng Y., Zhou X., miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011 117 16 4293 4303 2-s2.0-79955967742 10.1182/blood-2010- 12-322503
83. O'Connell R. M., Taganov K. D., Boldin M. P., Cheng G., Baltimore D., MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences of the United States of America 2007 104 5 1604 1609 2-s2.0-33846845071 10.1073/pnas.0610731104 (Pubitemid 46214637)
84. Trotta R., Chen L., Ciarlariello D., Josyula S., Mao C., Costinean S., Yu L., Butchar J. P., Tridandapani S., Croce C. M., a Caligiuri M., MiR-155 regulates IFN- γ production in natural killer cells. Blood 2012 119 15 3478 3485 10.1182/blood-2011-12-398099
85. O'Connell R. M., Chaudhuri A. A., Rao D. S., Baltimore D., Inositol phosphatase SHIP1 is a primary target of miR-155. Proceedings of the National Academy of Sciences of the United States of America 2009 106 17 7113 7118 2-s2.0-66349137358 10.1073/pnas.0902636106
86. Klein U., Lia M., Crespo M., Siegel R., Shen Q., Mo T., Ambesi-Impiombato A., Califano A., Migliazza A., Bhagat G., Dalla-Favera R., The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010 17 1 28 40 2-s2.0-73649116987 10.1016/j.ccr.2009.11.019
87. Iorio M. V., Croce C. M., MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Molecular Medicine 2012 4 3 143 159 10.1002/emmm.201100209
88. Johnnidis J. B., Harris M. H., Wheeler R. T., Stehling-Sun S., Lam M. H., Kirak O., Brummelkamp T. R., Fleming M. D., Camargo F. D., Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008 451 7182 1125 1129 2-s2.0-39849096995 10.1038/nature06607 (Pubitemid 351317447)
89. * targets Prf1 and GzmB expression to regulate NK cell cytotoxicity. Blood 2011 118 20 5476 5486 10.1182/blood-2011-04-347526
90. * promotes NK cell cytotoxicity against human hepatoma cells via targeting the transcription factor HMBOX1. Cancer Science 2012 103 4 645 652 10.1111/j.1349-7006.2012.02207.x
91. Gasser S., Orsulic S., Brown E. J., Raulet D. H., The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005 436 7054 1186 1190 2-s2.0-24144443517 10.1038/nature03884 (Pubitemid 41232299)
92. Champsaur M., Lanier L. L., Effect of NKG2D ligand expression on host immune responses. Immunological Reviews 2010 235 1 267 285 2-s2.0-77951683908 10.1111/j.0105-2896.2010.00893.x
93. Stern-Ginossar N., Elefant N., Zimmermann A., Wolf D. G., Saleh N., Biton M., Horwitz E., Prokocimer Z., Prichard M., Hahn G., Goldman-Wohl D., Greenfield C., Yagel S., Hengel H., Altuvia Y., Margalit H., Mandelboim O., Host immune system gene targeting by a viral miRNA. Science 2007 317 5836 376 381 2-s2.0-34547132780 10.1126/science.1140956 (Pubitemid 47106378)
94. Nachmani D., Stern-Ginossar N., Sarid R., Mandelboim O., Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host and Microbe 2009 5 4 376 385 2-s2.0-64649083498 10.1016/j.chom.2009.03.003
95. Stern-Ginossar N., Gur C., Biton M., Horwitz E., Elboim M., Stanietsky N., Mandelboim M., Mandelboim O., Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nature Immunology 2008 9 9 1065 1073 2-s2.0-50049115540 10.1038/ni.1642
96. Ishida F., Kwong Y. L., Diagnosis and management of natural killer-cell malignancies. Expert Review of Hematology 2010 3 5 593 602 2-s2.0-78049436912 10.1586/ehm.10.51
97. Watters R. J., Liu X., Loughran T. P., T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias. Leukemia Lymphoma 2011 52 12 2217 2225 10.3109/10428194.2011.593276
98. Semenzato G., Marino F., Zambello R., State of the art in natural killer cell malignancies. International Journal of Laboratory Hematology 2012 34 2 117 128 10.1111/j.1751-553X.2011.01374.x
99. + T cells. Journal of Experimental Medicine 2001 193 2 219 231 2-s2.0-0035862325 10.1084/jem.193.2.219 (Pubitemid 32524453)
100. Fehniger T. A., Suzuki K., van Deusen J. B., Cooper M. A., Freud A. G., Caligiuri M. A., Fatal leukemia in interleukin-15 transgenic mice. Blood Cells, Molecules, and Diseases 2001 27 1 223 230 2-s2.0-0035046525 10.1006/bcmd.2001. 0379 (Pubitemid 32299778)
101. Paik J. H., Jang J. Y., Jeon Y. K., Kim W. Y., Kim T. M., Heo D. S., Kim C. W., MicroRNA-146a downregulates NF B activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clinical Cancer Research 2011 17 14 4761 4771 2-s2.0-79960434259 10.1158/1078-0432.CCR-11-0494
102. Ng S. B., Yan J., Huang G., Selvarajan V., Tay J. L. S., Lin B., Bi C., Tan J., Kwong Y. L., Shimizu N., Aozasa K., Chng W. J., Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma. Blood 2011 118 18 4919 4929 10.1182/blood-2011-07-364224
103. Ramakrishnan R., Donahue H., Garcia D., Tan J., Shimizu N., Rice A. P., Ling P. D., Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PloS One 2011 6 11 e27271